Skip to content
Trial Eligibility
Menu

Trial in HPV Prevention for the U.S. Vietnamese Community

NCT07637630

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietnamese. PRIMARY AIM To assess the feasibility and acceptability of each of the four digital HERO intervention components in a pilot optimization trial using the MOST framework.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • HPV-related Cancers
  • HPV Vaccination

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Northwestern University
Last updated on ClinicalTrials.gov
June 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Northwestern University · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.